Firstly, the result verified the STC2 gain of expression in osteosarcoma comparing to normal osteoblasts based on the experiment fact that 41 of the 43 cancer samples showed positive staining (positive ratio 95.3%), meanwhile only 4 of 43 paired normal osteoblasts showed mild staining (staining ratio 9.3%). This evidence concerns the gene STC2 and cancer.